The genomic landscape of schwannoma
Gelareh Zadeh, Kenneth Aldape and colleagues present an integrative genomic analysis of schwannomas. In addition to finding recurrent mutations in ARID1A , ARID1B and DDR1 , they identify a recurrent SH3PXD2A - HTRA1 fusion that confers increased proliferation, invasion and in vivo transformation, a...
Saved in:
Published in | Nature genetics Vol. 48; no. 11; pp. 1339 - 1348 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.11.2016
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 1061-4036 1546-1718 1546-1718 |
DOI | 10.1038/ng.3688 |
Cover
Summary: | Gelareh Zadeh, Kenneth Aldape and colleagues present an integrative genomic analysis of schwannomas. In addition to finding recurrent mutations in
ARID1A
,
ARID1B
and
DDR1
, they identify a recurrent
SH3PXD2A
-
HTRA1
fusion that confers increased proliferation, invasion and
in vivo
transformation, and is associated with sensitivity to MEK inhibition.
Schwannomas are common peripheral nerve sheath tumors that can cause debilitating morbidities. We performed an integrative analysis to determine genomic aberrations common to sporadic schwannomas. Exome sequence analysis with validation by targeted DNA sequencing of 125 samples uncovered, in addition to expected
NF2
disruption, recurrent mutations in
ARID1A
,
ARID1B
and
DDR1
. RNA sequencing identified a recurrent in-frame
SH3PXD2A-HTRA1
fusion in 12/125 (10%) cases, and genomic analysis demonstrated the mechanism as resulting from a balanced 19-Mb chromosomal inversion on chromosome 10q. The fusion was associated with male gender predominance, occurring in one out of every six men with schwannoma. Methylation profiling identified distinct molecular subgroups of schwannomas that were associated with anatomical location. Expression of the
SH3PXD2A-HTRA1
fusion resulted in elevated phosphorylated ERK, increased proliferation, increased invasion and
in vivo
tumorigenesis. Targeting of the MEK-ERK pathway was effective in fusion-positive Schwann cells, suggesting a possible therapeutic approach for this subset of tumors. |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1061-4036 1546-1718 1546-1718 |
DOI: | 10.1038/ng.3688 |